Archive | Headline RSS feed for this section
Tom Brokaw Bravely Facing Cancer Diagnosis
February 12, 2014
ORIGINAL STORY: http://www.insideedition.com/headlines/7780-tom-brokaw-bravely-facing-cancer-diagnosis INSIDE EDITION: Airdate: 02/12/2014 There is an outpouring of support for legendary broadcaster Tom Brokaw as he bravely battles bone marrow cancer. Brokaw stepped down as anchor of the NBC Nightly News in 2004. He was diagnosed last August with multiple myeloma—cancer that affects white blood cells in bone marrow—but has kept it secret until […]
James R. Berenson, MD
President and CEO - James R. Berenson, MD, Inc.
Medical & Scientific Director - Institute for Myeloma
& Bone Cancer Research (IMBCR)
Chief Executive Officer - Oncotherapeutics
- Combined TRAF6 Targeting and Proteasome Blockade has Anti-tumor and Anti-bone Resorptive Effects
- Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
- Outcomes in Multiple Myeloma Patients Evaluated
- Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
- Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma
- Combined TRAF6 Targeting and Proteasome Blockade has Anti-tumor and Anti-bone Resorptive Effects
- The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo
- Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting
- Understanding Myeloma News About Secondary Cancers and Clotting
-
Dedication of “Determination”
March 6, 2014
0 Comments